期刊文献+

Par-4基因过表达调节肾母细胞瘤顺铂敏感性的实验研究 被引量:1

Experimental study about the regulating effect of Par-4 gene overexpression on the nephroblastoma sensitivity to cisplatin
下载PDF
导出
摘要 目的:研究Par-4基因过表达对肾母细胞瘤顺铂敏感性的调节作用。方法:培养肾母细胞瘤SKNEP-1细胞并分为四组,对照组用不含血清及药物的RMPI-1640处理,顺铂组用含有5μg/mL顺铂的无血清RMPI-1640处理,Par-4组用无血清RMPI-1640转染Par-4过表达质粒,顺铂+Par-4组用含有5μg/mL顺铂的无血清RMPI-1640转染Par-4过表达质粒。处理后测定细胞的增殖活力及促凋亡基因、迁移及侵袭基因的表达量。结果:不同条件处理后8h、16h、24h,顺铂组、Par-4组、顺铂+Par-4组的细胞增殖活力值均显著低于对照组,顺铂+Par-4组的细胞增殖活力值显著低于顺铂组、Par-4组;不同条件处理后24h,顺铂组、Par-4组、顺铂+Par-4组细胞中Bim、PDCD4、WT1、RGS4、Axin、KAI1、E-cadherin、PPARγ、PTEN的mRNA表达量均显著高于对照组,GDNF、GFRα1、TUBB3、NME1、FGF1的mRNA表达量均显著低于对照组;顺铂+Par-4组细胞中Bim、PDCD4、WT1、RGS4、Axin、KAI1、E-cadherin、PPARγ、PTEN的mRNA表达量显著高于顺铂组、Par-4组,GDNF、GFRα1、TUBB3、NME1、FGF1的mRNA表达量显著低于顺铂组、Par-4组。结论:Par-4基因过表达能够增加肾母细胞瘤对顺铂的敏感性,降低细胞增殖活力并促进细胞凋亡、抑制细胞迁移和侵袭。 Objective:To study the regulating effect of Par-4 gene overexpression on the nephroblastoma sensitivity to cisplatin.Methods:Nephroblastoma SK-NEP-1 cells were cultured and divided into four groups,control group were treated with RMPI-1640 without serum or drugs,cisplatin group were treated with serum-free RMPI-1640 containing 5μg/mL cisplatin,Par-4 group were transfected by Par-4 overexpression plasmids with serum-free RMPI-1640,and cisplatin+ Par-4 group were transfected by Par-4 overexpression plasmid with serum-free RMPI-1640 containing 5μg/mL cisplatin.The cell proliferation activity as well the expression of apoptosis genes,migration genes and invasion genes was measured.Results:Eight hours,16 hand 24 hafter different conditions of treatment,the cell proliferation activity of cisplatin group,Par-4 group and cisplatin+ Par-4 group were significantly lower than that of control group,and the cell proliferation activity of cisplatin+ Par-4 group was significantly lower than that of cisplatin group and Par-4 group;24 hafter different conditions of treatment,Bim,PDCD4,WT1,RGS4,Axin,KAI1,E-cadherin,PPARγand PTEN mRNA expression in cisplatin group,Par-4 group and cisplatin+Par-4 group were greatly higher than those in control group whereas GDNF,GFRα1,TUBB3,NME1 and FGF1 mRNA expression were greatly lower than those in control group;Bim,PDCD4,WT1,RGS4,Axin,KAI1,E-cadherin,PPARγand PTEN mRNA expression in cisplatin+ Par-4 group were greatly higher than those in cisplatin group and Par-4 group whereas GDNF,GFRα1,TUBB3,NME1 and FGF1 mRNA expression were greatly significantly lower than those in cisplatin group and Par-4 group.Conclusion:Par-4 gene overexpression can increase the nephroblastoma sensitivity to cisplatin,reduce cell proliferation activity,promote apoptosis and inhibit cell migration and invasion.
出处 《海南医学院学报》 CAS 2017年第22期3043-3046,共4页 Journal of Hainan Medical University
基金 恩施州科技项目(160825)~~
关键词 肾母细胞瘤 前列腺凋亡反应因子-4 顺铂 敏感性 Nephroblastoma Prostate apoptosis response-4 Cisplatin Sensitivity
  • 相关文献

参考文献2

二级参考文献19

  • 1DAVIDOFF AM. Wilms' tumor[J]. Curr Opin Pediatr, 2009, 21(3) :357-364.
  • 2PASTORE G, ZNAOR A, SPREAFICO F, et al. Malignant renal tumours incidence and survival in European children (1978-1997) : report from the Automated Childhood Cancer In- formation System project[J]. Eur J Cancer, 2006, 42 (13) : 2103-2114.
  • 3SAEBO M, SKJELBRED CF, NEXO BA,et al. Increased mR- NA expression levels of ERCC1, OGG1 and RAI in colorectal adenomas and carcinomas[J]. BMC Cancer, 2006, 16(6) :208-215.
  • 4OLAUSSEN KA, DUNANT A, FOURET P, et al. DNA re- pair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy[J]. N Engl J Med, 2006, 355 (10) : 983- 991.
  • 5VILMAR A, GARCIA-FONCILLAS J, HUARRIZ M, et al. RT-PCR versus immunohistochemistry for correlation and quantification of ERCC1, BRCA1, TUBB3 and RRM1 in NSCLC[J]. Lung Cancer, 2012, 75(3):306-312.
  • 6PRESS MF, SAUTER G, BUYSE M, et al. Alteration of to- poisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracyclinc-based chemotherapy[J]. J Clin Oncol, 2011, 29(7):859-867.
  • 7NAKAMURA L, RITCHEY M. Current management of Wilms' tumor[J]. Curt Urol Rep, 2010, 11(1):58-65.
  • 8TSODIKOV OV, JVANOV D, ORELLI B, et al. Structural basis for the recruitment of ERCCI-XPF to nucleotide excision repair complexes by XPA[J]. EMBO, 2007, 26 (22) : 4768- 4776.
  • 9FAUTREL A, ANDRIEUX L, MUSSO O, et al. Overexpres- sion of the two nucleotide excision repair genes ERCC1 and XPC in human hepatocellular carcinoma[J]. J Hepatol, 2005, 43(2) : 288-293.
  • 10ZHOU W, LIU G, PARK S, et al. Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer[J]. Cancer Epidemiol Biomarkers Prey, 2005, 14 (2): 491-496.

共引文献9

同被引文献6

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部